LABU ETF holdings (NYSE) - Page 8 | MetaTrader

Abrir gráfico completo Full chart

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

KROS Keros Therapeutics Inc. 359.81 K 20.09 K 0.06%

IVVD Invivyd Inc 328.48 K 188.78 K 0.06%

SVRA Savara Inc 321.92 K 59.62 K 0.06%

ABUS Arbutus Biopharma Corp. 320.65 K 77.64 K 0.06%

TYRA Tyra Biosciences Inc 316.06 K 10.26 K 0.05%

RZLT Rezolute Inc 308.87 K 92.48 K 0.05%

MDXG MiMedx Group Inc. 234.95 K 45.98 K 0.04%

IRWD Ironwood Pharmaceuticals, Inc. 210.35 K 43.02 K 0.04%

NOVOB DC CVR 128.72 K

OmniAb Inc. 14.78 K

INHIBRX INC CVR 164.17 K

VERVE THERAPEUTICS INC (CVR) 82.53 K

DREYFUS

1
2
3
4
5
6
7
8

Notícias

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors